Recuro Health Further Expands Digital Solution Platform: Acquires My Legacy Decision Support App, Integrates Genetic Profiles to Enhance Disease Management & Care Coordination
DALLAS--(BUSINESS WIRE)--Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, announces the acquisition of MyLegacy, a risk stratification tool and clinical decision support application which uses proprietary algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute. This acquisition further increases the scope and capabilities of Recuro’s digital health platform, pairing automated genetic data gathering with complex care planning to save time, make care more precise and streamline the full continuum of care.
Q&A: Cleveland Clinic Innovations’ new head has his eyes trained on the future
In a wide-ranging interview, Dr. Geoff Vince, the new executive director of Cleveland Clinic Innovations, discussed his plans for how the commercialization arm will operate, the technologies he thinks will drive interest and whether the pandemic has changed approaches to innovation.
Cleveland Clinic, IBM, Aetna teaming up to launch blockchain health firm
Cleveland Clinic, IBM, Aetna and Anthem have partnered to form a blockchain health firm, called Avaneer Health. The Chicago-based healthcare company will aim to use blockchain capabilities to make healthcare more efficient and reduce administrative costs, according to a June 9 news release.
Announcing Avaneer Health: Accelerating Healthcare Delivery and Powering the Next Generation of Care Experiences
Leading healthcare companies announce the formation of Avaneer Health and its incoming CEO, Stuart Hanson. Avaneer Health is a new venture designed to create a seamless, end-to-end experience and eliminate the inefficiencies afflicting today's healthcare system. Driven by its vision for a more productive and people-centered industry, Avaneer Health is building an inclusive network, breakthrough infrastructure and solutions to unlock healthcare's potential. The groundbreaking company enters the market with an expert team of change agents; investment from top industry players; and a technology backbone designed to support a vast array of platforms for greater applicability and use in reducing administrative costs, accelerating care and improving the experience for people and their families.
Why health IT innovation in Cleveland is unlike 'anywhere else in the world': 3 Qs with Cleveland Clinic Innovations' new leader
As its newest executive director, D. Geoffrey Vince, PhD, is spearheading Cleveland Clinic Innovations as the commercialization unit undergoes a strategy restructuring and backs the system's health IT expansions.
Cleveland Clinic, Mayo Clinic + 8 health IT moves in May
Some of the biggest companies in health IT, including Cerner, Biofourmis and Kettering Health, recently announced personnel changes. Below are 10 health IT executive moves that occurred since May 1.
Cleveland Clinic fills new role: executive director of innovations
D. Geoffrey Vince, a biomedical engineer at the health system, will lead new efforts to build out computer science and data research, with the goal of drug discovery and other clinical innovations.
Cleveland Clinic wants digital health venture partner for commercialization arm: 4 details
Cleveland Clinic is looking to expand its commercialization arm with the addition of a new digital health venture partner who will oversee the health system's innovations and creation of health IT startups.
Cleveland clinic researchers identify new drug target for treating aggressive prostate cancer
According to new findings published in Science Translational Medicine, Cleveland Clinic researchers have identified a promising drug target for treating and preventing aggressive, drug-resistant prostate cancer.
Cleveland Clinic Appoints D. Geoffrey Vince, Ph.D., Executive Director of Cleveland Clinic Innovations
Cleveland Clinic has named D. Geoffrey Vince, Ph.D., as Executive Director of Cleveland Clinic Innovations. In this newly formed role, Dr. Vince will align Cleveland Clinic’s technology development strategies with scientific and research priorities – including unprecedented growth in data and computing sciences – to accelerate the discoveries of new treatments and drugs. He will build strategic partnerships and alliances in these areas to drive revenue growth through commercialization of intellectual property.